Understanding ReNU2
A plain-language guide to what researchers have discovered about this newly recognized cause of severe neurodevelopmental disorder in children.
This page is for informational purposes only and does not constitute medical advice.
One of the reasons ReNU2 United was founded is to support families affected by ReNU2—a newly recognized neurodevelopmental disorder caused by mutations in the gene RNU2-2. This discovery was unexpected, because RNU2-2 was long considered inactive, or just a "pseudogene." We now know it plays a vital role in early brain development, and that small changes within it can have profound consequences for children.
The Gene Behind ReNU2: RNU2-2
RNU2-2 produces a small piece of RNA that forms part of a critical molecular machine called the major spliceosome. The spliceosome's job is to process nearly all human gene transcripts by removing non-coding segments called introns—a step essential for producing functional proteins. Because the spliceosome is involved in processing virtually the entire genome, disruptions to any of its components can have wide-ranging effects on development.
Despite its importance, RNU2-2 is a non-coding gene, meaning it doesn't produce a protein directly—instead, it produces an RNA molecule that becomes a functional part of this larger cellular machinery. This is part of why it was overlooked for so long.
The Two Forms of ReNU2
Dominant Form De Novo
Caused by a spontaneous mutation—a new change that arises in the child and is not inherited from either parent. This form typically affects only one child in a family.
Two specific variants are responsible, occurring at positions 4 and 35 of the RNU2-2 gene.
Recessive Form Inherited
Results from inheriting two variants—one from each parent. Each parent typically carries one copy and is themselves unaffected.
Variants responsible for the recessive form can occur throughout many different locations within the gene, making them more varied and harder to predict.
The Scientific Discovery
Researchers analyzed data from the UK's 100,000 Genomes Project, comparing children with unexplained neurodevelopmental conditions to others in the dataset. RNU2-2 emerged as a significant finding, alongside another gene the team had previously studied.
The initial discovery involved nine children, each carrying a de novo mutation. The finding was then confirmed across 16 additional cases in separate datasets—bringing the total to 25 affected individuals in the original research cohort.
Why This Was Surprising
RNU2-2 was originally classified as a pseudogene—a genetic "fossil" assumed to be inactive. The research team demonstrated that it is in fact active and plays a vital role during development. The mutations occur in regions directly involved in splicing, where the RNU2-2 RNA interacts with the rest of the spliceosome machinery.
Interestingly, when researchers examined blood samples from affected children, they did not find obvious splicing errors in other genes. This suggests the effects may be specific to brain cells, or may emerge only at certain stages of fetal development—a key area of ongoing research.
Symptoms and Impact
Children with ReNU2 show a combination of neurological and developmental challenges. Severity can vary, but many features appear consistently across documented cases.
How Does ReNU2 Compare to ReNU Syndrome (RNU4-2)?
ReNU2 is related to ReNU Syndrome, which is caused by mutations in the gene RNU4-2. While there is significant clinical overlap between the two conditions, the seizures seen in ReNU2 tend to be more severe and distinctive than those associated with ReNU Syndrome. Both genes encode components of the same spliceosome machinery, and ReNU2 United works closely with the ReNU Syndrome community.
Diagnosis & Genetic Testing
Because RNU2-2 is a non-coding gene, standard genetic tests often miss it entirely. Understanding which tests can and cannot detect ReNU2 is critical for families and the clinicians who care for them.
| Test Type | Detects ReNU2? | Notes |
|---|---|---|
| Whole Genome Sequencing (WGS) | ✔ Yes | Scans all DNA including non-coding regions. Currently the primary method for identifying RNU2-2 variants. |
| Targeted Variant Testing | ✔ Yes | Once a specific variant is found in a family member, targeted testing can confirm whether relatives carry the same change. |
| Whole Exome Sequencing (WES) | ✘ No | Only examines protein-coding genes. RNU2-2 is non-coding and will not appear on this test. |
| Standard Autism / ID Panels | ✘ No | Typically limited to coding genes. RNU2-2 is not included on most standard panels. |
| Custom Gene Panels | ~ Sometimes | Providers can request custom panels that include RNU2-2, but only if they are already aware of the gene—highlighting the need for ongoing advocacy and education. |
Connect With ReNU2 United
Whether you are a family navigating a new diagnosis or a clinician seeking more information, we are here to help connect you with support and resources.
Get in TouchThis site is strictly an informational website and does not provide medical advice, diagnosis, or treatment. The content is not intended to be a substitute for professional medical advice. Always seek the advice of a physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.